In a move that will potentially push the Philippines further toward "normalcy" two years into the coronavirus disease (COVID-19) pandemic, the Food and Drug Administration (FDA) has approved the Pfizer-BioNTech vaccine for emergency use among Filipino children five to 11 years old.